We found a significant decrease in the percentage of anhedonic animals among celecoxib-treated stress mice, and a shortened duration of floating in celecoxib-treated animals in the Porsolt test, which further highlights a potential role for COX-2 in the mechanisms of depression and points to the therapeutic potential of its inhibition. This evidence concerns the gene PTGS2 and depressive symptom measurement.